siRNAs: Applications in functional genomics and potential as therapeutics

Nature Reviews Drug Discovery

Volumn 3, Issue 4, 2004, Pages 318-329

  Dorsett, Yair ^a   Tuschl, Thomas ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTIVIRUS AGENT; BIOTIN; DNA DIRECTED RNA POLYMERASE III; DOUBLE STRANDED RNA; FLUORESCEIN; FOMIVIRSEN; INTERFERON; LENTIVIRUS VECTOR; MORPHOLINE DERIVATIVE; NUCLEIC ACID BASE; PARVOVIRUS VECTOR; PHOSPHOROTHIOIC ACID; PUROMYCIN; RETROVIRUS VECTOR; RIBONUCLEASE H; RIBOZYME; RNA; SMALL INTERFERING RNA;

ADENO ASSOCIATED VIRUS; CLINICAL TRIAL; DRUG EFFICACY; DRUG SYNTHESIS; GENE EXPRESSION; GENE FUNCTION; GENE LIBRARY; GENE MAPPING; GENE MUTATION; GENE TARGETING; GENETIC SCREENING; HIGH THROUGHPUT SCREENING; HUMAN; MAMMAL CELL; MOLECULE; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; RAT; REVIEW; SILENCER GENE; VIRAL GENE DELIVERY SYSTEM;

EID: 3242677639     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1345     Document Type: Review

References (196)

1. Elbashir, S. M., Lendeckel, W. & Tuschl, T. RNA interference is mediated by 21 and 22 nt RNAs. Genes Dev. 15, 188-200 (2001).
2. Hamilton, A. J. & Baulcombe, D. C. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 206, 950-952 (1999).
3. Fire, A. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811 (1998).
4. Montgomery, M. K., Xu, S. & Fire, A. RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 95, 15502-15507 (1998).
5. Waterhouse, P. M., Graham, M. W. & Wang, M. B. Virus resistance and gene silencing in plants can be induced by simultaneous expression of sense and antisense RNA. Proc. Natl Acad. Sci. USA 95, 13959-13964 (1998).
6. Kennerdell, J. R. & Carthew, R. W. Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway. Cell 95, 1017-1026 (1998).
7. Ngo, H., Tschudi, C., Gull, K. & Ullu, E. Double-stranded RNA induces mRNA degradation in Trypanosoma brucei. Proc. Natl Acad. Sci. USA 95, 14687-14692 (1998).
8. Cogoni, C. & Macino, G. Homology-dependent gene silencing in plants and fungi: a number of variations on the same theme. Curr. Opin. Microbiol. 2, 657-662 (1999).
9. Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H. & Schreiber, R. D. How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264 (1998).
10. Hammond, S. M., Bernstein, E., Beach, D. & Hannon, G. J. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404, 293-296 (2000).
11. Zamore, P. D., Tuschl, T., Sharp, P. A. & Bartel, D. P. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101, 25-33 (2000).
12. Elbashir, S. M., Martinez, J., Patkaniowska, A., Lendeckel, W. & Tuschl, T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20, 6877-6888 (2001).
13. Elbashir, S. M. et al. Duplexes of 21 -nucleotide RNAs mediate RNA interference in mammalian cell culture. Nature 411, 494-498 (2001).
14. Caplen, N. J., Parrish, S., Imani, F., Fire, A. & Morgan, R. A. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl Acad. Sci. USA 98, 9742-9747 (2001).
15. Bitko, V. & Barik, S. Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses. BMC Microbiol. 1, 34 (2001).
16. Scherer, L. J. & Rossi, J. J. Approaches for the sequence-specific knockdown of mRNA. Nature Biotechnol. 21, 1457-1465 (2003).
17. Braasch, D. A. & Corey, D. R. Novel antisense and peptide nucleic acid strategies for controlling gene expression. Biochemistry 41, 4503-4510 (2002).
18. Heasman, J. Morpholino oligos: making sense of antisense? Dev. Biol. 243, 209-214 (2002).
19. Schubert, S. et al. RNA cleaving '10-23' DNAzymes with enhanced stability and activity. Nucleic Acids Res. 31, 5982-5992 (2003).
20. Chakraborti, S. & Banerjea, A. C. Inhibition of HIV-1 gene expression by novel DNA enzymes targeted to cleave HIV-1 TAR RNA: potential effectiveness against all HIV-1 isolates. Mol. Ther. 7, 817-826 (2003).
21. Santoro, S. W. & Joyce, G. F. A general purpose RNA-cleaving DNA enzyme. Proc. Natl Acad. Sci. USA 94, 4262-4266 (1997).
22. Fortes, P. et al. Inhibiting expression of specific genes in mammalian cells with 5′ end-mutated U1 small nuclear RNAs targeted to terminal exons of pre-mRNA. Proc. Natl Acad. Sci. USA 100, 8264-8269 (2003).
23. Kurreck, J. Antisense technologies. Improvement through novel chemical modifications. Eur. J. Biochem. 270, 1628-1644 (2003).
24. Baker, B. F. et al. 2′-O-(2-methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J. Biol. Chem. 272, 11994-2000 (1997).
25. Lu, Q. L. et al. Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse. Nature Med. 9, 1009-1014 (2003).
26. Uil, T. G., Haisma, H. J. & Rots, M. G. Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities. Nucleic Acids Res. 31, 6064-6078 (2003).
27. Doudna, J. A. & Cech, T. R. The chemical repertoire of natural ribozymes. Nature 418, 222-228 (2002).
28. Kuwabara, T., Warashina, M. & Taira, K. Cleavage of an inaccessible site by the maxizyme with two independent binding arms: an alternative approach to the recruitment of RNA helicases. J. Biochem. (Tokyo) 132, 149-155 (2002).
29. Michienzi, A. & Rossi, J. J. Intracellular applications of ribozymes. Methods Enzymol. 341, 581-596 (2001).
30. Good, P. D. et al. Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther. 4, 45-54 (1997).
31. Bernstein, E., Caudy, A. A., Hammond, S. M. & Hannon, G. J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363-366 (2001).
32. Martinez, J., Patkaniowska, A., Urlaub, H., Lührmann, R. & Tuschl, T. Single-stranded antisense siRNAs guide target RNA cleavage in RNA. Cell 110, 563-574 (2002).
33. Zeng, Y. & Cullen, B. R. RNA interference in human cells is restricted to the cytoplasm. RNA 8, 855-860 (2002).
34. Wassenegger, M. & Pelissier, T. A model for RNA-mediated gene silencing in higher plants. Plant Mol. Biol. 37, 349-362 (1998).
35. Mette, M. F., Aufsatz, W., van der Winden, J., Matzke, M. A. & Matzke, A. J. M. Transcriptional silencing and promoter methylation triggered by double-stranded RNA. EMBO J. 19, 6194-6201 (2000).
36. Jones, A. L., Thomas, C. L. & Maule, A. J. De novo methylation and co-suppression induced by a cytoplasmically replicating plant RNA virus. EMBO J. 17, 6385-6393 (1998).
37. Wang, M.-B., Wesley, S. V., Finnegan, E. J., Smith, N. A. & Waterhouse, P. M. Replicating satellite RNA induces sequence-specffic DNA methylation and truncated transcripts in plants. RNA 7, 16-28 (2001).
38. Llave, C., Kasschau, K. D., Rector, M. A. & Carrington, J. C. Endogenous and silencing-associated small RNAs in plants. Plant Cell 14, 1605-1619 (2002).
39. Volpe, T. A. et al. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 297, 1833-1837 (2002).
40. Reinhart B. J. & Bartel, D. P. Small RNAs correspond to centromere heterochromatic repeats. Science 297, 1831 (2002).
41. Hall, I. M. et al. Establishment and maintenance of a heterochromatin domain. Science 297, 2232-2237 (2002).
42. Verdel, A. et al. RNAi-mediated targeting of heterochromatin by the RITS complex. Science 303, 672-676 (2004).
43. Pal-Bhadra, M., Bhadra, U. & Birchler, J. A. RNAi related mechanism affect both transcriptional and posttranscriptional transgene silencing in Drosophila. Mol. Cell 9, 315-327 (2002).
44. Pal-Bhadra, M. et al. Heterochromatic silencing and HP1 localization in Drosophila are dependent on the RNAi machinery. Science 303, 669-672 (2004).
45. Carrington, J. C. & Ambros, V. Role of microRNAs in plant and animal development. Science 301, 336-338 (2003).
46. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
47. Lee, Y., Jeon, K., Lee, J. T., Kim, S. & Kim, V. N. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21, 4663-4670 (2002).
48. Olsen, P. H. & Ambros, V. The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans, by blocking LIN-14 protein synthesis after the initiation of translation. Dev. Biol. 216, 671-680 (1999).
49. Seggerson, K., Tang, L. & Moss, E. G. Two genetic circuits repress the Caenorhabditis elegans heterochronic gene lin-28 after translation initiation. Dev. Biol. 243, 215-225 (2002).
50. Wightman, B., Ha, I. & Ruvkun, G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elagans. Cell 75, 855-862 (1993).
51. Nelson, P. T., Hatzigeorgiou, A. G. & Mourelatos, Z. miRNP:mRNA association in polyribosomes in a human neuronal cell line. RNA 10, 387-394 (2004).
52. Kim, J. et al. Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc. Natl Acad. Sci. USA 101, 360-365 (2004).
53. Hutvágner, G. & Zamore, P. D. A microRNA in a multiple-turnover RNAi enzyme complex. Science 297, 2056-2060 (2002).
54. 3 receptor. Nucleic Acids Res. 31, 2117-2126 (2003).
55. Miyagishi, M., Hayashi, M. & Taira, K. Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells. Antisense Nucleic Acid Drug Dev. 13, 1-7 (2003).
56. Kretschmer-Kazemi Far, R. & Sczakiel, G. The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides. Nucleic Acids Res. 31, 4417-4424 (2003).
57. Grunweller, A. et al. Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2′ -O-methyl RNA, phosphorothioates and small interfering RNA. Nucleic Acids Res. 31, 3185-3193 (2003).
58. Xu, Y. et al. Effective small interfering RNAs and phosphorothioate antisense DNAs have different preferences for target sites in the luciferase mRNAs. Biochem. Biophys. Res. Commun. 306, 712-717 (2003).
59. Vickers, T. A. et al. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J. Biol. Chem. 278, 7108-7118 (2003).
60. Bertrand, J. R. et al. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem. Biophys. Res. Commun. 296, 1000-1004 (2002).
61. Schwarz, D. S. et al. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115, 199-208 (2003).
62. Khvorova, A., Reynolds, A. & Jayasena, S. D. Functional siRNAs and miRNAs exhibit strand bias. Cell 115, 209-216 (2003).
63. Harborth, J. et al. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev. 13, 83-105 (2003).
64. Liu, Y., Braasch, D. A., Nulf, C. J. & Corey, D. R. Efficient and isoform-selective inhibition of cellular gene expression by peptide nucleic acids. Biochemisty 43, 1921-1927 (2004).
65. Eckstein, F. Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them? Antisense Nucleic Acid Drug Dev. 10, 117-121 (2000).
66. Yokota, T. et al. siRNA-based inhibition specific for mutant SOD1 with single nucleotide alternation in familial ALS, compared with ribozyme and DNA enzyme. Biochem. Biophys. Res. Commun. 314, 283-291 (2004).
67. Lee, N. S. et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nature Biotechnol. 20, 500-505 (2002).
68. Drew, H. R. et al. RNA hairpin loops repress protein synthesis more strongly than hammerhead ribozymes. Eur. J. Biochem. 208, 260-273 (1999).
69. Lebedeva, I. & Stein, C. A. Antisense of oligonucleotides: promise and reality. Annu. Rev. Pharmacol. Toxicol. 41, 403-419 (2001).
70. Hafner, M. et al. Antimetastatic effect of CpG DNA mediated by type I IFN. Cancer Res. 61, 5523-6528 (2001).
71. Roman, M. et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nature Med. 3, 849-854 (1997).
72. Rothenfusser, S., Tuma, E., Wagner, M., Endres, S. & Hartmann, G. Recent advances in immunostimulatory CpG oligonucleotides. Curr. Opin. Mol. Ther. 5, 98-106 (2003).
73. Dove, A. Antisense and sensibility. Nature Biotechnol. 20, 121-124 (2002).
74. Lai, J. C. et al. G3139 (oblimersen) may inhibit prostate cancer cell growth in a partially bis-CpG-dependent non-antisense manner. Mol. Cancer Ther. 2, 1031-1043 (2003).
75. Tsuchihashi, Z., Khosla, M. & Herschlag, D. Protein enhancement of hammerhead ribozyme catalysts. Science 262, 99-102 (1993).
76. Heil, F. et al. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303, 1526-1529 (2004).
77. Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S. & Reis e Sousa, C. Innate antiviral responses by means of TLR7-Mediated recognition of single-stranded RNA. Science 303, 1529-1531 (2004).
78. Jackson, A. L. et al. Expression profiling reveals off-target gene regulation by RNAi. Nature Biotechnol. 21, 635-637 (2003).
79. Chi, J. T. et al. Genomewide view of gene silencing by small interfering RNAs. Proc. Natl Acad. Sci. USA 100, 6343-6346 (2003).
80. Semizarov, D. et al. Specificity of short interfering RNA determined through gene expression signatures. Proc. Natl Acad. Sci. USA 100, 6347-6352 (2003).
81. Persengiev, S. P., Zhu, X. & Green, M. R. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10, 12-18 (2004).
82. Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H. & Williams, B. R. Activation of the interferon system by short-interfering RNAs. Nature Cell Biol. 5, 834-839 (2003).
83. Bridge, A. J., Pebernard, S., Ducraux, A., Nicoulaz, A. L. & Iggo, R. Induction of an interferon response by RNAi vectors in mammalian cells. Nature Genet. 34, 263-264 (2003).
84. Giles, R. V. & Tidd, D. M. Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase H using chimeric methylphosphonodiester/phosphodiester structures. Nucleic Acids Res. 20, 763-770 (1992).
85. Monia, B. P. et al. Evaluation of 2′-modified oligonucleotides; containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 258, 14514-14522 (1993).
86. Saxena, S., Jonsson, Z. O. & Dutta, A. Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J. Biol. Chem. 278, 44312-44319 (2003).
87. Doench, J. G., Petersen, C. P. & Sharp, P. A. siRNAs can function as miRNAs. Genes Dev. 17, 438-442 (2003).
88. Zeng, Y., Yi, R. & Cullen, B. R. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc. Natl Acad. Sci. USA 100, 9779-9784 (2003).
89. Editorial. Whither RNAi? Nature Cell Biol. 5, 489-490 (2003).
90. Harborth, J., Elbashir, S. M., Bechert, K., Tuschl, T. & Weber, K. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci. 114, 4557-4565 (2001).
91. Miller, V. M. et al. Allele-specific silencing of dominant disease genes. Proc. Natl Acad. Sci. USA 100, 7195-7200 (2003).
92. Ding, H. et al. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2, 209-217 (2003).
93. Abdelgany, A., Wood, M. & Beeson, D. Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interference. Hum. Mol. Genet. 12, 2637-2644 (2003).
94. Gonzalez-Alegre, P., Miller, V. M., Davidson, B. L. & Paulson, H. L. Toward therapy for DYT1 dystonia: allele-specific silencing of mutant TorsinA. Ann. Neurol. 53, 781-787 (2003).
95. Tuschl, T. Expanding small RNA interference. Nature Biotechnol. 20, 446-448 (2002).
96. Xia, H., Mao, Q., Paulson, H. L. & Davidson, B. L. siRNA-mediated gene silencing in vitro and in vivo. Nature Biotechnol. 20, 1006-1010 (2002).
97. Arts, G. J. et al. Adenoviral vectors expressing siRNAs for discovery and validation of gene function. Genome. Res. 13, 2325-2332 (2003).
98. Shen, C., Buck, A. K., Liu, X., Winkler, M. & Reske, S. N. Gene silencing by adenovirus-delivered siRNA. FEBS Lett. 539, 111-114 (2003).
99. Zhao, L. J., Jian, H. & Zhu, H. Specific gene inhibition by adenovirus-mediated expression of small interfering RNA. Gene 316, 137-141 (2003).
100. Tomar, R. S., Matta, H. & Chaudhary, P. M. Use of adeno-associated viral vector for delivery of small interfering RNA. Oncogene 22, 5712-5715 (2003).
101. Hommel, J. D., Sears, R. M., Georgescu, D., Simmons, D. L. & DiLeone, R. J. Local gene knockdown in the brain using viral-mediated RNA interference. Nature Med. 9, 1539-1544 (2003).
102. Brummelkamp, T. R., Bernards, R. & Agami, R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2, 243-247 (2002).
103. Wiznerowicz, M. & Trono, D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 77, 8957-8961 (2003).
104. Rubinson, D. A. et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic, mice by RNA interference. Nature Genet. 33, 401-406 (2003).
105. An, D. S. et al. Efficient lentiviral vectors for short hairpin RNA delivery into human cells. Hum. Gene Ther. 14, 1207-1212 (2003).
106. van de Wetering, M. et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep. 4, 609-615 (2003).
107. Czauderna, F. et al. Inducible shRNA expression for application in a prostate cancer mouse model. Nucleic Acids Res. 31, e127 (2003).
108. Matsukura, S., Jones, P. A. & Takai, D. Establishment of conditional vectors for hairpin siRNA knockdowns. Nucleic Acids Res. 31, e77 (2003).
109. Shinagawa, T. & Ishii, S. Generation of Ski-knockdown mice by expressing a long double-strand RNA from an RNA polymerase II promoter. Genes Dev. 17, 1340-1346 (2003).
110. Matsuda, T. & Cepko, C. L. Electroporation and RNA interference in the rodent retina in vivo and in vitro. Proc. Natl Acad. Sci. USA 101, 16-22 (2003).
111. Mellitzer, G., Hallonet, M., Chen, L. & Ang, S. Spatial and temporal 'knock down' of gone expression by electroporation of double-stranded RNA and morpholinos into early postimplantation mouse embryos. Mech. Dev. 118, 57 (2002).
112. Bai, J. et al. RNAi reveals doublecortin is required for radial migration in rat neocortex. Nature Neurosci. 6, 1277-1283 (2003).
113. Calegari, F., Haubensak, W., Yang, D., Huttner, W. B. & Buchholz, F. Tissue-specific RNA interference in postimplantation mouse embryos with endoribonuclease-prepared short interfering RNA. Proc. Natl Acad. Sci. USA 99, 14236-14240 (2002).
114. Reich, S. J. et al. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol. Vis. 9, 210-216 (2003).
115. Sorensen, D. R., Leirdal, M. & Sioud, M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol. Biol. 327, 761-766 (2003).
116. Kong, X. C., Barzaghi, P. & Ruegg, M. A. Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference. EMBO Rep. 5, 183-188 (2004).
117. McCaffrey, A. P. et al. RNA interference in adult mice. Nature 418, 38-39 (2002).
118. Lewis, D. L., Hagstrom, J. E., Loomis, A. G., Wolff, J. A. & Herweijer, H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nature Genet. 32, 107-108 (2002).
119. Giladi, H. et al. Small interfering RNA inhibits hepatitis B virus replication in mice. Mol. Ther. 8, 769-776 (2003).
120. Klein, C. et al. Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA. Gastroenterology 125, 9-18 (2003).
121. Zender, L. et al. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc. Natl Acad. Sci. USA 100, 7797-7802 (2003).
122. Song, E. et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nature Med. 9, 347-351 (2003).
123. McCaffrey, A. P. et al. Inhibition of hepatitis B virus in mice by RNA interference. Nature Biotechnol. 21, 639-644 (2003).
124. Sullenger, B. A. & Gilboa, E. Emerging clinical applications of RNA. Nature 418, 252-258 (2002).
125. Stevenson, M. Dissecting HIV-1 through RNA interference. Nature Rev. Immunol. 3, 851-858 (2003).
126. Opalinska, J. B. & Gewirtz, A. M. Nucleic-acid therapeutics: basic principles and recent applications. Nature Rev. Drug Discov. 1, 503-514 (2002).
127. Brenner, T. et al. The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis. FASEB J. 17, 214-222 (2003).
128. Geary, R. S. et al. Absolute bioavailability, of 2′-O-(2-methoxyethyl)-modified antisense oligonucleotides following intraduodenal instillation in rats. J. Pharmacol. Exp. Ther. 296, 898-904 (2001).
129. Sussman, H. E. Success for oral antisense therapy. Drug. Discov. Today 8, 516-517 (2003).
130. Karande, P., Jain, A. & Mitragotri, S. Discovery of transdermal penetration enhancers by high-throughput screening. Nature Biotechnol. 22, 192-197 (2004).
131. Gautam, A., Densmore, C. L., Xu, B. & Waldrep, J. C. Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery. Mol. Ther. 2, 63-70 (2000).
132. Carmell, M. A., Zhang, L., Conklin, D. S., Hannon, G. J. & Rosenquist, T. A. Germline transmission of RNAi in mice. Nature Struct. Biol. 10, 91-92 (2003)
133. Hemann, M. T. et al. An epi-allelic, series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nature Genet. 33, 396-400 (2003).
134. Davies, J. A. et al. Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation. Hum. Mol. Genet. 13, 235-246 (2003).
135. Carpenter, A. E. & Sabatini, D. M. Systematic genome-wide screens of gene function. Nature Rev. Genet. 5, 11-22 (2004).
136. Kamath, R. S. et al. Systematic functional analysis of the Caenorhabditis elegans, genome using RNAi. Nature 421, 231-237 (2003).
137. Ashrafi, K. et al. Genome-wide RNA analysis of Caenorhabditis elegans fat regulatory genes. Nature 421, 268-272 (2003).
138. Fraser, A. G. et al. Functional genomic, analysis of C. elegans, chromosome I by systematic RNA interference. Nature 408, 325-330 (2000).
139. Gonczy P., et al. Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III. Nature 408, 331-336 (2000).
140. Maeda, I., Kohara, Y., Yamamoto, M. & Sugimoto, A. Large-scale analysis of gene function in Caenorhabditis elegans by high-throughput RNAi. Curr. Biol. 11, 171-176 (2001).
141. Piano, F. et al. Gene clustering based on RNAi phenotypes of ovary-enriched genes in C. elegans. Curr. Biol. 12, 1959-19564 (2002).
142. Piano, F., Schetter, A. J., Mangone, M., Stein, L. & Kemphues, K. J. RNAi analysis of genes expressed in the ovary of Caenorhabditis, elegans. Curr. Biol. 10, 1619-1622 (2000).
143. Simmer, F., et al. Genome-wide RNAi of C. elegans using the hypersensitive rrf-3 strain reveals novel gene functions. PLoS Biol. 1, E12 (2003).
144. Vastenhouw, N. L. et al. A genome-wide screen identifies 27 genes involved in transposon silencing in C. elegans. Curr. Biol. 13, 1311-1316 (2003).
145. Pothrof, J. et al. Identification of genes that protect the C. elegans genome against mutations by genome-wide RNAi. Genes Dev. 117, 443-448 (2003).
146. Lee, S. S. et al. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nature Genet. 33, 40-48 (2003).
147. Lum, L. et al. Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells. Science 299, 2039-2045 (2003).
148. Kiger, A. et al. A functional genomic analysis of cell morphology using RNA interference. J. Biol. 2, 27 (2003).
149. Boutros, M. et al. Genome-wide RNAi analysis of growth and viability in Drosophila cells. Science 303, 832-835 (2004).
150. Nolan, P. M., Kapfhamer, D. & Bucan, M. Random mutagenesis screen for dominant behavioral mutations in mice. Methods 13, 379-395 (1997).
151. Rinchik, E. M. & Carpenter, D. A. N-ethyl-N-nitrosourea mutagenesis of a 6- to 11-cM subregion of the Fah-Hbb interval of mouse chromosome 7: completed testing of 4557 gametes and deletion mapping and complementation analysis of 31 mutations. Genetics 152, 373-383 (1999).
152. Nolan, P. M. et al. A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nature Genet. 25, 440-443 (2000).
153. Hrabe de Angelis, M. H. et al. Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nature Genet. 25, 444-447 (2000).
154. Kile, B. T. et al. Functional genetic analysis of mouse chromosome 11. Nature 425, 81-86 (2003).
155. Oates, A. C., Bruce, A. E. & Ho, R. K. Too much interference: injection of double-stranded RNA has nonspecific effects in the zebrafish embryo. Dev. Biol. 224, 20-28 (2000).
156. Lim, L. P., Glasner, M. E., Yeka, S., Burge, C. B. & Bartel, D. P. Vertebrate microRNA genes. Science 299, 1540 (2003).
157. Zhou, Y., Ching, Y.-P., Kok, K. H., Kung, H. & Jin, D.-J. Post-transcriptional suppression of gene expression in Xenopus embryos by small interfering RNAs. Nucleic Acids Res. 30, 1664-1669 (2002).
158. Pekarik, V. et al. Screening for gene function in chicken embryo using RNAi and electroporation. Nature Biotechnol. 21, 93-96 (2003).
159. Svoboda, P., Stein, P., Hayashi, H. & Schultz, R. M. Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA inteference. Development 127, 4147-4156 (2000).
160. Stein, P., Svoboda, P. & Schultz, R. M. Transgenic RNAi in mouse oocytes: a simple and fast approach to study gene function. Dev. Biol. 256, 187-193 (2003).
161. Aza-Blanc, P. et al. Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol. Cell 12, 627-637 (2003).
162. Zheng, L. et al. An approach to genomewide screens of expressed small interfering RNAs in mammalian cells. Proc. Natl Acad. Sci. USA 101, 135-140 (2003).
163. Brummelkamp, T. R., Nijman, S. M., Dirac, A. M. & Bernards, R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature 424, 797-801 (2003).
164. Berns, K. et al. A large-scale RNAi screen in human cells identifies novel components of the p53 pathway. Nature (in the press).
165. Walters, D. K. & Jelinek, D. F. The effectiveness of double-stranded short inhibitory RNAs (siRNAs) may depend on the method of transfection. Antisense Nucleic Acid Drug Dev. 12, 411-418 (2002).
166. Weil, D. et al. Targeting the kinesin Eg5 to monitor siRNA transfection in mammalian cells. Biotechniques 33, 1244-1248 (2002).
167. Zhou, A., Scoggin, S., Gaynor, R. B. & Williams, N. S. Identification of NF-κB-regulated genes induced by TNFα utilizing expression profiling and RNA interference. Oncogene 22, 2054-2064 (2003).
168. Williams, N. S. et al. Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin. Cancer Res. 9, 931-946 (2003).
169. Ziauddin, J. & Sabatini, D. M. Microarrays of cells expressing defined cDNAs. Nature 411, 107-110 (2001).
170. Bailey, S. N., Wu, R. Z. & Sabatini, D. M. Applications of transfected cell microarrays in high-throughput drug discovery. Drug Discov. Today 7, S113-S118 (2002).
171. Mousses, S. et al. RNAi microarray analysis in cultured mammalian cells. Genome Res 13, 2341-2347 (2003).
172. Reynolds, A. et al. Rational siRNA design for RNA interference. Nature Biotechnol. 22, 326-330 (2004).
173. Hohjoh, H. Enhancement of RNAi activity by improved siRNA duplexes. FEBS Lett. 557, 193-198 (2004).
174. Silva, J. M., Sachidanandam, R. & Hannon, G. J. Free energy lights the path toward more effective RNAi. Nature Genet. 35, 303-305 (2003).
175. Elbashir, S. M., Harborth, J., Weber, K. & Tuschl, T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26, 199-213 (2002).
176. Shirane, D. et al. Enzymatic production of RNAi libraries from cDNAs. Nature Genet 36, 190-196 (2004).
177. Sen, G., Wehrman, T. S., Myers, J. W. & Blau, H. M. Restriction enzyme-generated siRNA (REGS) vectors and libraries. Nature Genet. 35, 183-189 (2004).
178. Kawasaki, H., Suyama, E., Iyo, M. & Taira, K. siRNAs generated by recombinant human Dicer induce specific and significant but target site-independent gene silencing in human cells. Nucleic Acids Res. 31, 981-987 (2003).
179. Howard, K. Unlocking the money-making potential of RNAi. Nature Biotechnol. 21, 1441-1446 (2003).
180. Song, E. et al. Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages. J. Virol. 77, 7174-7181 (2003).
181. Filleur, S. et al. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth. Cancer Res. 63, 3919-3922 (2003).
182. Yang, G., Thompson, J. A., Fang, B. & Liu, J. Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumor growth in a model of human ovarian cancer. Oncogene 22, 5694-5701 (2003).
183. Li, K., Lin, S. Y., Brunicardi, F. C. & Seu, P. Use of RNA inteference to target cyclin E-overexpressing hepatocellular carcinoma. Cancer Res. 83, 3593-3597 (2003).
184. Verma, U. N., Surabhi, R. M., Schmaltieg, A., Becerra, C. & Gaynor, R. B. Small interfering RNAs directed against β-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin. Cancer. Res. 9, 1291-1300 (2003).
185. Yoshinouchi, M. et al. In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA. Mol. Ther. 8, 762-768 (2003).
186. Pieken, W. A., Olsen, D. B., Benseler, F., Aurup, H. & Eckstein, F. Kinetic characterization of ribonucleases-resistant 2′-modified hammerhead ribozymes. Science 253, 314-317 (1991).
187. Beigelman, L. et al. Chemical modification of hammerhead ribozymes. Catalytic activity and nuclease resistance. J. Biol. Chem. 270, 25702-25708 (1995).
188. Levin, A. A. A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides. Biochim. Biophys. Acta 1489, 69-84 (1999).
189. Czauderna, F. et al. Structural variations and stabilising modificatons of synthetic siRNAs in mammalian cells. Nucleic Acids Res. 31, 2705-2716 (2003).
190. Chiu, Y. L. & Rana, T. M. siRNA function in RNAi: a chemical modification analysis. RNA 9, 1034-1048 (2003).
191. Amarzguioui, M., Holen, T., Babaie, E. & Prydz, H. Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res. 31, 589-595 (2003).
192. Braasch, D. A. et al. RNA interference in mammalian cells by chemically-modified RNA. Biochemistry 42, 7967-7975 (2003).
193. Chiu, Y. L. & Rana, T. M. RNAi in human cells. Basic structural and functional features of small interfering RNA. Mol. Cell 10, 549-561 (2002).
194. Holen, T., Amarzguioui, M., Wiiger, M. T., Babaie, E. & Prydz, H. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res. 30, 1757-1766 (2002).
195. Holen, T., Amarzguioui, M., Babaie, E. & Prydz, H. Similar behaviour of single-strand and double-strand siRNAs suggests they act through a common RNAi pathway. Nucleic Acids Res. 31, 2401-2407 (2003).
196. Capodici, J., Kariko, K. & Weissman, D. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA inteference. J. Immunol. 169, 5196-5201 (2002).